{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:15:39Z","timestamp":1790709339306,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.jaip.2021.02.048","type":"journal-article","created":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T12:19:23Z","timestamp":1615119563000},"page":"2315-2320.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Real-World Effectiveness of Anti\u2013IL-5\/5R Therapy in Severe Atopic Eosinophilic Asthma with Fungal Sensitization"],"prefix":"10.1016","volume":"9","author":[{"given":"Jaideep","family":"Dhariwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew P.","family":"Hearn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne E.","family":"Kavanagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e1inne","family":"d\u2019Ancona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cris","family":"Roxas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian D.","family":"Kent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra M.","family":"Nanzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2021.02.048_bib1","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1183\/09031936.06.00074705","article-title":"The link between fungi and severe asthma: a summary of the evidence","volume":"27","author":"Denning","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2021.02.048_bib2","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1365-2222.1997.tb00672.x","article-title":"Comparative degree and type of sensitization to common indoor and outdoor allergens in subjects with allergic rhinitis and\/or asthma","volume":"27","author":"Boulet","year":"1997","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2021.02.048_bib3","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1111\/j.1365-2222.2009.03339.x","article-title":"Comparison of skin prick tests with specific serum immunoglobulin E in the diagnosis of fungal sensitization in patients with severe asthma","volume":"39","author":"O\u2019Driscoll","year":"2009","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2021.02.048_bib4","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1046\/j.1365-2222.2003.01783.x","article-title":"Sensitization to fungi: epidemiology, comparative skin tests, and IgE reactivity of fungal extracts","volume":"33","author":"Mari","year":"2003","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2021.02.048_bib5","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2466-5-4","article-title":"Mold sensitization is common amongst patients with severe asthma requiring multiple hospital admissions","volume":"5","author":"O\u2019Driscoll","year":"2005","journal-title":"BMC Pulmon Med"},{"key":"10.1016\/j.jaip.2021.02.048_bib6","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.jaip.2016.11.015","article-title":"Fungal sensitization is associated with increased risk of life-threatening asthma","volume":"5","author":"Medrek","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.02.048_bib7","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1080\/17476348.2016.1249853","article-title":"Developments in the diagnosis and treatment of allergic bronchopulmonary aspergillosis","volume":"10","author":"Agarwal","year":"2016","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.jaip.2021.02.048_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/MCP.0000000000000740","article-title":"The impact of fungal allergic sensitization on asthma","volume":"27","author":"Kao","year":"2021","journal-title":"Curr Opin Pulmon Med"},{"key":"10.1016\/j.jaip.2021.02.048_bib9","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1093\/mmy\/myy063","article-title":"Challenging cases in fungal asthma","volume":"57","author":"Agarwal","year":"2019","journal-title":"Med Mycol"},{"key":"10.1016\/j.jaip.2021.02.048_bib10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/03007995.2016.1233101","article-title":"Burden of systemic glucocorticoid-related complications in severe asthma","volume":"33","author":"Lefebvre","year":"2017","journal-title":"Curr Med Res Opinion"},{"key":"10.1016\/j.jaip.2021.02.048_bib11","doi-asserted-by":"crossref","first-page":"1902273","DOI":"10.1183\/13993003.02273-2019","article-title":"Prevalence and recovery of adrenal insufficiency in steroid-dependent asthma patients receiving biologic therapy","volume":"56","author":"Nanzer","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2021.02.048_bib12","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1164\/rccm.200805-737OC","article-title":"Randomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitization: the Fungal Asthma Sensitization Trial (FAST) study","volume":"179","author":"Denning","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2021.02.048_bib13","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaci.2013.09.050","article-title":"Effectiveness of voriconazole in the treatment of Aspergillus fumigatus-associated asthma (EVITA3 study)","volume":"134","author":"Agbetile","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.02.048_bib14","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1016\/j.jaip.2020.05.055","article-title":"Omalizumab is an effective intervention in severe asthma with fungal sensitization","volume":"8","author":"Wark","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.02.048_bib15","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.chest.2020.08.2083","article-title":"Real world effectiveness of benralizumab in severe eosinophilic asthma","volume":"159","author":"Kavanagh","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2021.02.048_bib16","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.chest.2020.03.042","article-title":"Real-world effectiveness and the characteristics of a \u201csuper-responder\u201d to mepolizumab in severe eosinophilic asthma","volume":"158","author":"Kavanagh","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2021.02.048_bib17","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1007\/s12325-019-01191-2","article-title":"Ability of serum IgE concentration to predict exacerbation risk and benralizumab efficacy for patients with severe eosinophilic asthma","volume":"37","author":"Jackson","year":"2020","journal-title":"Adv Ther"},{"key":"10.1016\/j.jaip.2021.02.048_bib18","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1183\/09031936.00202013","article-title":"International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma","volume":"43","author":"Chung","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2021.02.048_bib19","doi-asserted-by":"crossref","first-page":"1902259","DOI":"10.1183\/13993003.02259-2019","article-title":"Adherence to corticosteroids and clinical outcomes in mepolizumab therapy for severe asthma","volume":"55","author":"d\u2019Ancona","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2021.02.048_bib20","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/cea.12848","article-title":"The relationship between biomarkers of fungal allergy and lung damage in asthma","volume":"47","author":"Woolnough","year":"2017","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2021.02.048_bib21","doi-asserted-by":"crossref","first-page":"344","DOI":"10.18176\/jiaci.0122","article-title":"Allergic fungal airway disease","volume":"26","author":"Rick","year":"2016","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2021.02.048_bib22","author":"Kavanagh"},{"key":"10.1016\/j.jaip.2021.02.048_bib23","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jaip.2014.12.008","article-title":"Clinical efficacy and immunologic effects of omalizumab in allergic bronchopulmonary aspergillosis","volume":"3","author":"Voskamp","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.02.048_bib24","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.rmed.2016.11.019","article-title":"Beneficial effects of omalizumab therapy in allergic bronchopulmonary aspergillosis: a synthesis review of published literature","volume":"122","author":"Li","year":"2017","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2021.02.048_bib25","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1183\/13993003.01475-2015","article-title":"A\u00a0randomised trial of glucocorticoids in acute-stage allergic bronchopulmonary aspergillosis complicating asthma","volume":"47","author":"Agarwal","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2021.02.048_bib26","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1183\/09031936.00139513","article-title":"Treatment options in severe fungal asthma and allergic bronchopulmonary aspergillosis","volume":"43","author":"Moss","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2021.02.048_bib27","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.alit.2015.04.004","article-title":"ILC2s and fungal allergy","volume":"64","author":"Kita","year":"2015","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaip.2021.02.048_bib28","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.4049\/jimmunol.1102832","article-title":"IL-33-responsive lineage\u2212 CD25+ CD44(hi) lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs","volume":"188","author":"Bartemes","year":"2012","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2021.02.048_bib29","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.anai.2017.07.008","article-title":"Characteristics of severe asthma with fungal sensitization","volume":"119","author":"Masaki","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2021.02.048_bib30","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/cea.13680","article-title":"Fungal sensitization and its relationship to mepolizumab response in patients with severe eosinophilic asthma","volume":"50","author":"Wardlaw","year":"2020","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2021.02.048_bib31","first-page":"1","article-title":"Use of monoclonal antibodies for allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis: literature review","volume":"14","author":"Eraso","year":"2020","journal-title":"Therapeut Adv Respir Dis"},{"key":"10.1016\/j.jaip.2021.02.048_bib32","first-page":"A1262","article-title":"Disseminated aspergillosis after IL-5 therapy for severe asthma","volume":"201","author":"Wood","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2021.02.048_bib33","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.anai.2019.08.071","article-title":"Dupilumab efficacy in patients with uncontrolled, moderate-to-severe allergic bronchopulmonary aspergillosis","volume":"123","author":"Corren","year":"2019","journal-title":"Ann Allergy Asthma Immunol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219821002919?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219821002919?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:29:41Z","timestamp":1761974981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219821002919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S2213219821002919"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2021.02.048","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-World Effectiveness of Anti\u2013IL-5\/5R Therapy in Severe Atopic Eosinophilic Asthma with Fungal Sensitization","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2021.02.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}